M&A Deal Summary

Discovery Life Sciences Acquires In Vitro ADMET

On December 2, 2021, Discovery Life Sciences acquired life science company In Vitro ADMET

Acquisition Highlights
  • This is Discovery Life Sciences’ 4th transaction in the Life Science sector.
  • This is Discovery Life Sciences’ 2nd transaction in the United States.
  • This is Discovery Life Sciences’ 1st transaction in Maryland.

M&A Deal Summary

Date 2021-12-02
Target In Vitro ADMET
Sector Life Science
Buyer(s) Discovery Life Sciences
Deal Type Add-on Acquisition

Target

In Vitro ADMET

Columbia, Maryland, United States
website
In Vitro ADMET provides premium hepatocyte and enterocyte products and related services to assist all of your in vitro ADMET research needs. In Vitro ADMET was founded in 2004 and is based in Columbia, Maryland.

Search 191,161 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Discovery Life Sciences

Huntsville, Alabama, United States

website


Category Company
Founded 2018
Sector Life Science
DESCRIPTION

Discovery Life Sciences is a provider of biospecimen analysis, procurement, distribution, and genomic, cell-based and histology-based scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery’s sequencing and bioinformatics division, a globally recognized service laboratory that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Discovery Life Sciences was formed in 2018 and is based in Huntsville, Alabama.


DEAL STATS #
Overall 4 of 7
Sector (Life Science) 4 of 7
Type (Add-on Acquisition) 4 of 6
State (Maryland) 1 of 1
Country (United States) 2 of 5
Year (2021) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-18 Targos

Kassel, Germany

Targos GmbH is the molecular pathology laboratory in Europe, to significantly expand its global tissue biomarker services. Targos has delivered highly standardized development and application of clinical biomarkers for the international pharmaceutical and diagnostic industries and has helped to approve many breakthrough therapies and companion diagnostics. Targos GmbH was founded in 2005 and is based in Kassel, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-05 Corning - Gentest Business

Corning, New York, United States

Corning's Gentest Business includes absorption and transport reagents, recombinant metabolic enzymes, tissue fractions, hepatocytes, other ADME toxicology products, and contracted research services.

Buy -